Form 4: Belite Bio CEO Reports Stock Transaction
Insider Transaction (Form 4)
Yu-Hsin Lin, Chief Executive Officer and a Director of Belite Bio, Inc, reported a transaction in 5,000 shares of common stock on October 29, 2026.
Summary
- Other acquisition/disposition: acquired 5,000 Ordinary Share on October 29, 2026; holds 187,949 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Yu-Hsin Lin — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-29 | Other acquisition/disposition | Ordinary Share | 5,000 | — | — | 187,949 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-29 | Other acquisition/disposition (5,000 shares) |
Keywords
insider transaction, Form 4, BLTE, BELITE BIO, INC, neutral, Yu-Hsin Lin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.